Treatment: relapsing phase of multiple sclerosis

被引:0
|
作者
Kappos, L [1 ]
Leppert, D
Radu, EV
机构
[1] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland
[2] Univ Basel Hosp, Dept Neuroradiol, CH-4031 Basel, Switzerland
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S23 / S24
页数:2
相关论文
共 50 条
  • [31] Phase IIb trial of BHT-3009 for the treatment of relapsing-remitting multiple sclerosis
    Garren, Hideki
    Gianettoni, Jill
    Robinson, William
    Tersini, Karen
    Valone, Frank
    Steinman, Lawrence
    ANNALS OF NEUROLOGY, 2007, 62 : S70 - S70
  • [32] Phase II study for the treatment of relapsing-remitting multiple sclerosis patients with biomoduline T
    Lorenzo Antonio, Gamez Morales
    Lara Rodriguez Rosa, F.
    Martin Roman, Rodriguez
    Monteagudo Alina, Gonzalez-Quevedo
    Carriera Rebeca, Fernandez
    Silva Natalia, Marzoa
    REVISTA MEXICANA DE NEUROCIENCIA, 2007, 8 (01): : 28 - 31
  • [33] A case of lymphoma in a patient on teriflunomide treatment for relapsing multiple sclerosis
    Landais, Anne
    Alhendi, Rabi
    Gouverneur, Amandine
    Teron-Aboud, Brigitte
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 17 : 92 - 94
  • [34] Understanding the treatment preferences of people with relapsing remitting multiple sclerosis
    Ford, H.
    Manzano, A.
    Eskyte, I.
    Pavitt, S.
    Pepper, G.
    Schmierer, K.
    Chataway, J.
    Potrata, B.
    Webb, E.
    Meads, D.
    Marti, J.
    Bekker, H.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 919 - 920
  • [35] The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
    Hermann, Robert
    Karlsson, Mats O.
    Novakovic, Ana M.
    Terranova, Nadia
    Fluck, Markus
    Munafo, Alain
    CLINICAL PHARMACOKINETICS, 2019, 58 (03) : 283 - 297
  • [36] Treatment of relapsing multiple sclerosis - recommendations of the Croatian Neurological Society
    Habek, Mario
    Adamec, Ivan
    Barun, Barbara
    Kes, Vanja Basic
    Raspopovic, Andrijana Bogoje
    Glavor, Klaudia Duka
    Gabelic, Tereza
    Grzincic, Tihana
    Jukic, Mirjam
    Jurasic, Miljenka-Jelena
    Kidemet-Piskac, Spomenka
    Komso, Milica
    Rimac, Julija
    Lazibat, Ines
    Lukic, Branka
    Marcinko, Anita
    Matijaca, Meri
    Ratkovic, Marija
    Sapina, Lidija
    Vuletic, Vladimira
    Zubonja, Tea Mirosevic
    Skoric, Magdalena Krbot
    CROATIAN MEDICAL JOURNAL, 2022, 63 (04) : 379 - 388
  • [37] Ofatumumab subcutaneous injection for the treatment of relapsing forms of multiple sclerosis
    Dalla Costa, G.
    Leocani, L.
    Comi, G.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2022, 18 (02) : 105 - 114
  • [38] CONTEMPORARY TREATMENT OPTIONS FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Salhofer-Polanyi, S.
    Leutmezer, F.
    DRUGS OF TODAY, 2014, 50 (05) : 365 - 383
  • [39] The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple Sclerosis
    Robert Hermann
    Mats O. Karlsson
    Ana M. Novakovic
    Nadia Terranova
    Markus Fluck
    Alain Munafo
    Clinical Pharmacokinetics, 2019, 58 : 283 - 297
  • [40] ORAL FINGOLIMOD FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Vosiliou, S.
    DRUGS OF TODAY, 2010, 46 (05) : 315 - 325